{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T17:39:14Z","timestamp":1744738754575},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00228-023-03601-5","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T21:28:33Z","timestamp":1703712513000},"page":"383-393","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Time series analysis of using the PDCA method combined with the Teach-back method to improve spontaneous reports of adverse drug reactions in a grade IIIA hospital in China"],"prefix":"10.1007","volume":"80","author":[{"given":"Bo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,27]]},"reference":[{"issue":"9237","key":"3601_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/s0140-6736(00)02799-9","volume":"356","author":"IR Edwars","year":"2000","unstructured":"Edwars IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356(9237):1255\u20131259. https:\/\/doi.org\/10.1016\/s0140-6736(00)02799-9","journal-title":"Lancet"},{"key":"3601_CR2","unstructured":"World Health Organization (2002)\u00a0Safety of medicines: a guide to detecting and reporting adverse drug reactions: why health professionals need to take action"},{"key":"3601_CR3","doi-asserted-by":"publisher","unstructured":"Bates DW (2001)\u00a0Costs of drug-related morbidity and mortality: enormous and growing rapidly. J Am Pharm Assoc (Wash)\u00a041(2):156\u20137.\u00a0https:\/\/doi.org\/10.1016\/s1086-5802(16)31242-6","DOI":"10.1016\/s1086-5802(16)31242-6"},{"key":"3601_CR4","doi-asserted-by":"publisher","unstructured":"Marques J et al (2014)\u00a0A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Int J Pharm Pract\u00a022(4):275\u201382.\u00a0https:\/\/doi.org\/10.1111\/ijpp.12078","DOI":"10.1111\/ijpp.12078"},{"key":"3601_CR5","doi-asserted-by":"publisher","unstructured":"Rottenkolber D et al (2011)\u00a0Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf 20(6):626\u201334.\u00a0https:\/\/doi.org\/10.1002\/pds.2118","DOI":"10.1002\/pds.2118"},{"key":"3601_CR6","doi-asserted-by":"publisher","unstructured":"Bouvy JC, De Bruin ML, Koopmanschap MA (2015)\u00a0Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf\u00a038(5):437\u201353.\u00a0https:\/\/doi.org\/10.1007\/s40264-015-0281-0","DOI":"10.1007\/s40264-015-0281-0"},{"key":"3601_CR7","doi-asserted-by":"publisher","unstructured":"Adisa R, Adeniyi OR, Fakeye TO (2019)\u00a0Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria. Int J Clin Pharm\u00a041(4):1062\u20131073.\u00a0https:\/\/doi.org\/10.1007\/s11096-019-00849-9","DOI":"10.1007\/s11096-019-00849-9"},{"key":"3601_CR8","doi-asserted-by":"publisher","unstructured":"Reumerman M et al (2018)\u00a0Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Eur J Clin Pharmacol\u00a074(10):1235\u20131248.https:\/\/doi.org\/10.1007\/s00228-018-2500-y","DOI":"10.1007\/s00228-018-2500-y"},{"key":"3601_CR9","unstructured":"Administration CNMP (2021)\u00a0Annual report on national monitoring of adverse drug reactions"},{"key":"3601_CR10","doi-asserted-by":"publisher","unstructured":"Hazell L, Shakir SA (2006)\u00a0Under-reporting of adverse drug reactions: a systematic review. Drug Saf\u00a029(5):385\u201396.\u00a0https:\/\/doi.org\/10.2165\/00002018-200629050-00003","DOI":"10.2165\/00002018-200629050-00003"},{"key":"3601_CR11","doi-asserted-by":"crossref","unstructured":"Edwards R, Olsson S, and Lindquist M (2005)\u00a0Global drug surveillance: the WHO programme for international drug monitoring. Pharmacoepidemiology 161\u2013183","DOI":"10.1002\/9780470059876.ch10"},{"key":"3601_CR12","doi-asserted-by":"publisher","unstructured":"Gahr M et al (2021)\u00a0Reporting, handling, and subjective importance of adverse drug reactions among general practitioners: an exploratory cross-sectional survey. Expert Opin Drug Saf\u00a020(8):979\u2013985.\u00a0https:\/\/doi.org\/10.1080\/14740338.2021.1933430","DOI":"10.1080\/14740338.2021.1933430"},{"key":"3601_CR13","doi-asserted-by":"publisher","unstructured":"Nadew SS, Beyene KG, Beza SW (2020)\u00a0Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia. PLoS One\u00a015(1):e0227712.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0227712","DOI":"10.1371\/journal.pone.0227712"},{"key":"3601_CR14","doi-asserted-by":"publisher","unstructured":"Hasford J et al (2002)\u00a0Physicians\u2019 knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol\u00a055(9):945\u201350.\u00a0https:\/\/doi.org\/10.1016\/s0895-4356(02)00450-x","DOI":"10.1016\/s0895-4356(02)00450-x"},{"key":"3601_CR15","doi-asserted-by":"publisher","unstructured":"Vallano A et al (2005)\u00a0Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol\u00a060(6):653\u2013658.\u00a0https:\/\/doi.org\/10.1111\/j.1365-2125.2005.02504.x","DOI":"10.1111\/j.1365-2125.2005.02504.x"},{"key":"3601_CR16","doi-asserted-by":"publisher","unstructured":"Herdeiro MT et al (2005)\u00a0Physicians\u2019 attitudes and adverse drug reaction reporting : a case-control study in Portugal. Drug Saf\u00a028(9): 825\u2013833.\u00a0https:\/\/doi.org\/10.2165\/00002018-200528090-00007","DOI":"10.2165\/00002018-200528090-00007"},{"key":"3601_CR17","doi-asserted-by":"publisher","unstructured":"Chatterjee S, Lyle N, Ghosh S (2006)\u00a0A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India. Drug Saf\u00a029(7):641\u2013642.\u00a0https:\/\/doi.org\/10.2165\/00002018-200629070-00009","DOI":"10.2165\/00002018-200629070-00009"},{"key":"3601_CR18","doi-asserted-by":"publisher","unstructured":"Cereza G et al (2010)\u00a0Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital. Eur J Clin Pharmacol\u00a066(9):937\u201345.\u00a0https:\/\/doi.org\/10.1007\/s00228-010-0856-8","DOI":"10.1007\/s00228-010-0856-8"},{"key":"3601_CR19","doi-asserted-by":"publisher","unstructured":"Fang H et al (2017)\u00a0Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China. BMC Pharmacol Toxicol\u00a018(1):49.\u00a0https:\/\/doi.org\/10.1186\/s40360-017-0159-0","DOI":"10.1186\/s40360-017-0159-0"},{"key":"3601_CR20","doi-asserted-by":"publisher","unstructured":"Pedr\u00f3s C et al (2009)\u00a0An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf\u00a032(1):77\u201383.\u00a0https:\/\/doi.org\/10.2165\/00002018-200932010-00007","DOI":"10.2165\/00002018-200932010-00007"},{"key":"3601_CR21","doi-asserted-by":"publisher","unstructured":"He W et al (2018)\u00a0Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China. Ther Clin Risk Manag\u00a014:2139\u20132147.https:\/\/doi.org\/10.2147\/tcrm.S178297","DOI":"10.2147\/tcrm.S178297"},{"key":"3601_CR22","doi-asserted-by":"publisher","unstructured":"Chang F et al (2017)\u00a0A time series analysis of the effects of financial incentives and mandatory clinical applications as interventions to improve spontaneous adverse drug reaction reporting by hospital medical staff in China. J Eval Clin Pract\u00a023(6):1316\u20131321.\u00a0\u00a0https:\/\/doi.org\/10.1111\/jep.12780","DOI":"10.1111\/jep.12780"},{"key":"3601_CR23","unstructured":"Ministry of Health of the People's Republic of China (2011)\u00a0Adverse drug reaction report and monitoring measures for the administration"},{"key":"3601_CR24","doi-asserted-by":"publisher","unstructured":"Qing-ping S et al (2014)\u00a0Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China. BMC Health Serv Res\u00a014:73.\u00a0https:\/\/doi.org\/10.1186\/1472-6963-14-73","DOI":"10.1186\/1472-6963-14-73"},{"key":"3601_CR25","doi-asserted-by":"publisher","unstructured":"Caplin M, Saunders\u00a0T (2015)\u00a0Utilizing teach-back to reinforce patient education: a step-by-step approach. Orthop Nurs 34(6):365\u20138; quiz 369\u201370.\u00a0https:\/\/doi.org\/10.1097\/nor.0000000000000197","DOI":"10.1097\/nor.0000000000000197"},{"key":"3601_CR26","doi-asserted-by":"crossref","unstructured":"MacLean S\u00a0et al (2018)\u00a0Evaluating the use of teach-back in simulation training to improve discharge communication practices of undergraduate nursing students. Clin Simul Nurs (22):13\u201321","DOI":"10.1016\/j.ecns.2018.06.005"},{"key":"3601_CR27","doi-asserted-by":"publisher","unstructured":"Talevski J et al (2020)\u00a0Teach-back: a systematic review of implementation and impacts. PLoS One\u00a015(4):e0231350.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0231350","DOI":"10.1371\/journal.pone.0231350"},{"key":"3601_CR28","doi-asserted-by":"publisher","unstructured":"Griffey RT et al (2015)\u00a0The impact of teach-back on comprehension of discharge instructions and satisfaction among emergency patients with limited health literacy: a randomized, controlled study. J Commun Healthc\u00a08(1):10\u201321.https:\/\/doi.org\/10.1179\/1753807615y.0000000001","DOI":"10.1179\/1753807615y.0000000001"},{"key":"3601_CR29","doi-asserted-by":"publisher","unstructured":"Kornburger C et al (2013)\u00a0Using \u201cteach-back\u201d to promote a safe transition from hospital to home: an evidence-based approach to improving the discharge process. J Pediatr Nurs\u00a028(3):282\u2013291.\u00a0https:\/\/doi.org\/10.1016\/j.pedn.2012.10.007","DOI":"10.1016\/j.pedn.2012.10.007"},{"key":"3601_CR30","doi-asserted-by":"publisher","unstructured":"Bernal JL, Cummins S, Gasparrini A (2017)\u00a0Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol\u00a046(1):348\u2013355.\u00a0https:\/\/doi.org\/10.1093\/ije\/dyw098","DOI":"10.1093\/ije\/dyw098"},{"key":"3601_CR31","unstructured":"Xue Y (2018)\u00a0Interrupted time-series analysis of drug occupancy ratio in patients undergoing total hip arthroplasty before and after clinical pathway management. Chin J Health Stat\u00a035(03):413\u2013414+419"},{"key":"3601_CR32","unstructured":"Jiang\u00a0et al (2022)\u00a0Impact of medical consumables zero-markup reform:evidence from hip fracture hospitalized patients in Sichuan. 49(10):1823\u20131827"},{"issue":"14","key":"3601_CR33","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2165\/00002018-200326140-00005","volume":"26","author":"JM Castel","year":"2003","unstructured":"Castel JM et al (2003) Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads. Drug Saf 26(14):1049\u20131055. https:\/\/doi.org\/10.2165\/00002018-200326140-00005","journal-title":"Drug Saf"},{"key":"3601_CR34","doi-asserted-by":"publisher","unstructured":"Edwards IR (1997) Adverse drug reactions: Finding the needle in the haystack. Bmj 315(7107):500. https:\/\/doi.org\/10.1136\/bmj.315.7107.500","DOI":"10.1136\/bmj.315.7107.500"},{"issue":"7456","key":"3601_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/bmj.329.7456.6","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, Darbyshire J (2004) Collecting and sharing information about harms. Bmj 329(7456):6\u20137. https:\/\/doi.org\/10.1136\/bmj.329.7456.6","journal-title":"Bmj"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-023-03601-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T09:06:11Z","timestamp":1708074371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-023-03601-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,27]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3601"],"URL":"https:\/\/doi.org\/10.1007\/s00228-023-03601-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,27]]},"assertion":[{"value":"17 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complies with the guidelines for human studies and is in accordance with the Declaration of Helsinki. This study was approved by the Ethics Committee of the Pidu District People\u2019s Hospital, Chengdu (code of ethics: [2022] 21). The research is anonymous and does not include personal privacy, thus we obtained an informed immunity from the Ethics Committee of the Pidu District People\u2019s Hospital, Chengdu.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}